美国 · SEC FORM 4
ARTIVION, INC.
AORT · NYSE · CIK 0000784199 · Healthcare · Medical Devices
内部人信号
0 qualifying P purchase groups
当前 180 天评分窗口
21 同一窗口内观察到的 Form 4 交易行
9 sales · 12 期权、代扣税、授予、赠与或其他交易行
为什么没有活跃信号?
评分构成
活跃窗口内没有合资格买入,因此不计算分数。缺失的输入不会被当作零分或看空信号。
为什么没有分数?
- 没有合资格公开市场买入可提供聚集度、规模、角色、近期性或确信度输入。
- 卖出及其他 Form 4 活动继续作为背景显示,不会形成负分。
卖出和其他 Form 4 活动会单独显示,不会形成负面买入信号。没有买入不会被评分为看空。
内部人活动时间轴
申报人轨道展示最近 180 天。符号形状区分交易类型;卖出仅作为背景。
Showing the six most active owners; 6 additional owner(s) remain in Form 4 申报证据.
买方广度、集中度与聚集买入
合资格买入进入 180 天研究窗口后,这些模块才会启用。
信号历史
Scores are archived only when the company qualifies for a published US buy-signal snapshot. 最近一次合资格买入: 2025-03-05 · SEMEDO ANTHONY B..
近期 Form 4 活动
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
市场背景
市场背景补充近期价格表现与风险信息,不影响内部人信号。
价格表现
- 1M
- -15.3%
- 3M
- -9.5%
- 6M
- -34.7%
- 12M
- —
波动率与流动性
- 波动率
- 48.2%
- Beta
- —
- 平均每日成交额
- —
估值
- 市值
- —
- P/E
- —
基本面
- 利润率
- 2.2%
- ROE
- 2.2%
- 细分行业
- Medical Devices
市场数据
价格数据截至:2026-10-03 · 价格来源:OpenBB/yfinance · 来自 SEC 申报文件:利润率, ROE · 财年截止日:2025-12-31 · Status: PASS
空头余额
空头余额是券商向 FINRA 申报的外部背景数据,不影响内部人信号。
- 空头股数
- 3,621,461
- 上期报告
- 3,284,198
- 日均成交量
- 654,874
- 回补天数
- 5.5
FINRA 结算日:2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数,每月两个结算日之后约一周公布;不是占已发行股份的比例。
历史股票买入
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2025-03-05 | SEMEDO ANTHONY B. | 买入 (P) | Common Stock | 2,100 | USD 25.31 | USD 53,145 | SEC 申报 ↗ |
| 2021-11-29 | Davis John E | 买入 (P) | Common Stock | 600 | USD 17.33 | USD 10,398 | SEC 申报 ↗ |
| 2021-11-29 | SEMEDO ANTHONY B. | 买入 (P) | Common Stock | 15,000 | USD 17.36 | USD 260,400 | SEC 申报 ↗ |
| 2020-09-16 | Mackin James P | 买入 (P) | Common Stock | 7,500 | USD 16.74 | USD 125,550 | SEC 申报 ↗ |
| 2020-09-16 | Davis John E | 买入 (P) | Common Stock | 10,000 | USD 16.65 | USD 166,500 | SEC 申报 ↗ |
| 2020-09-16 | Bullock James | 买入 (P) | Common Stock | 10,000 | USD 16.63 | USD 166,300 | SEC 申报 ↗ |
Form 4 申报证据
101 transaction lines in the latest 365-day window; 814 in local history.
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-09-10 | GREEN ANDREW M | 卖出 (S) | Common Stock | 11,480 | USD 24.97 | USD 286,656 | SEC 申报 ↗ |
| 2026-09-03 | GREEN ANDREW M | 卖出 (S) | Common Stock | 1,493 | USD 26.02 | USD 38,848 | SEC 申报 ↗ |
| 2026-09-02 | GREEN ANDREW M | 卖出 (S) | Common Stock | 6,510 | USD 27.27 | USD 177,528 | SEC 申报 ↗ |
展开近期 Form 4 证据 (30 grouped rows)
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-09-10 | GREEN ANDREW M | 卖出 (S) | Common Stock | 11,480 | USD 24.97 | USD 286,656 | SEC 申报 ↗ |
| 2026-09-03 | GREEN ANDREW M | 卖出 (S) | Common Stock | 1,493 | USD 26.02 | USD 38,848 | SEC 申报 ↗ |
| 2026-09-02 | GREEN ANDREW M | 卖出 (S) | Common Stock | 6,510 | USD 27.27 | USD 177,528 | SEC 申报 ↗ |
| 2026-08-19 | Mackin James P | 卖出 (S) | Common Stock | 70,000 | USD 28.96 | USD 2,027,200 | SEC 申报 ↗ |
| 2026-08-14 | GREEN ANDREW M | 卖出 (S) | Common Stock | 616 | USD 28.55 | USD 17,587 | SEC 申报 ↗ |
| 2026-08-14 | Berry Lance A | 卖出 (S) | Common Stock | 715 | USD 28.55 | USD 20,413 | SEC 申报 ↗ |
| 2026-08-12 | Holloway Jean F | 卖出 (S) | Common Stock | 977 | USD 28.49 | USD 27,835 | SEC 申报 ↗ |
| 2026-06-11 | GREEN ANDREW M | 卖出 (S) | Common Stock | 44,001 | USD 20.70 | USD 910,661 | SEC 申报 ↗ |
| 2026-06-11 | GREEN ANDREW M | 期权行权/转换 (M) | Common Stock | 44,001 | USD 13.39 | USD 589,078 | SEC 申报 ↗ |
| 2026-06-02 | SEMEDO ANTHONY B. | J (J) | Common Stock | 6,325 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-05-18 | Salveson Jon W | 奖励/授予 (A) | Common Stock | 7,576 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-05-18 | SEMEDO ANTHONY B. | 奖励/授予 (A) | Common Stock | 7,576 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-05-18 | Hoff Elizabeth A | 奖励/授予 (A) | Common Stock | 7,576 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-05-18 | Burbank Jeffrey H | 奖励/授予 (A) | Common Stock | 7,576 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-05-18 | Bullock James | 奖励/授予 (A) | Common Stock | 7,576 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-05-18 | Borgstrom Marna P | 奖励/授予 (A) | Common Stock | 7,576 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-05-18 | BEVEVINO DANIEL J | 奖励/授予 (A) | Common Stock | 7,576 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-05-18 | ACKERMAN THOMAS F | 奖励/授予 (A) | Common Stock | 7,576 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-05-14 | Borgstrom Marna P | 奖励/授予 (A) | Common Stock | 7,850 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-03-04 | Holloway Jean F | 卖出 (S) | Common Stock | 8,962 | USD 38.00 | USD 340,556 | SEC 申报 ↗ |
| 2026-03-03 | Stanton Marshall S. | 卖出 (S) | Common Stock | 2,149 | USD 37.78 | USD 81,189 | SEC 申报 ↗ |
| 2026-03-03 | Mackin James P | 卖出 (S) | Common Stock | 17,887 | USD 37.78 | USD 675,771 | SEC 申报 ↗ |
| 2026-03-03 | Horton Amy | 卖出 (S) | Common Stock | 901 | USD 37.78 | USD 34,040 | SEC 申报 ↗ |
| 2026-03-03 | Holloway Jean F | 卖出 (S) | Common Stock | 3,843 | USD 37.78 | USD 145,189 | SEC 申报 ↗ |
| 2026-03-03 | Davis John E | 卖出 (S) | Common Stock | 4,573 | USD 37.78 | USD 172,768 | SEC 申报 ↗ |
| 2026-03-03 | Berry Lance A | 卖出 (S) | Common Stock | 6,316 | USD 37.78 | USD 238,618 | SEC 申报 ↗ |
| 2026-03-02 | Stanton Marshall S. | 奖励/授予 (A) | Common Stock | 21,838 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-03-02 | Mackin James P | 奖励/授予 (A) | Common Stock | 116,948 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-03-02 | Horton Amy | 奖励/授予 (A) | Common Stock | 7,475 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-03-02 | Holloway Jean F | 奖励/授予 (A) | Common Stock | 27,795 | USD 0.00 | USD 0 | SEC 申报 ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
快照与身份
| 快照日期 | 2026-10-18 |
|---|---|
| 排名版本 | US-v1.2 |
| 数据质量 | PASS ELIGIBLE · — |
| 股票代码 | AORT |
| CIK | 0000784199 |
| 行业 | Healthcare |
| 细分行业 | Medical Devices Yahoo Finance |
| SEC SIC | 3841 Surgical & Medical Instruments & Apparatus |
| 交易所 | NYSE |
数据覆盖
| 本地 Form 4 历史 | 814 transaction lines from 2020-01-01 to 2026-09-10 7 P purchase lines · 296 S sale lines · 511 other lines |
|---|---|
| SEC 公司申报 | 打开 SEC 申报 ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.